Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene

Cell Death and Differentiation

Volumn 7, Issue 1, 2000, Pages 80-88

  Cameron, E R ^a   Morton, J ^a   Johnston, C J ^a   Irvine, J ^a   Bell, M ^a   Onions, D E ^a   Neil, J C ^a   Campbell, M ^a   Blyth, K ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Fas; Ipr; Lymphoma; Myc; T cell; Thymus

Indexed keywords

FAS ANTIGEN; MYC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE ACTIVATION; GENOTYPE; MOUSE; NONHUMAN; ONCOGENE C MYC; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; T CELL LYMPHOMA; TRANSGENE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD2; ANTIGENS, CD95; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; LEUKEMIA VIRUS, MURINE; LYMPHOMA; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED MRL LPR; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MYC; PROVIRUSES; THYMUS GLAND; TRANSGENES; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

ANIMALIA;

EID: 0034114731     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400630     Document Type: Article

References (51)

1. Wyllie AH, Kerr JFR and Currie AR (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306
2. Tsujimoto Y, Gorham J, Cossman J, Jaffe E and Groce CM (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393
3. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL and Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcription unit on 18. Cell 41: 889-906
4. Cleary ML and Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82: 7439-7443
5. McDonnell TJ and Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
7. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
8. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852
9. Askew DS, Ashmun RA, Simmons BC and Cleveland JL (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922
10. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
11. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR. (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212-214
12. Hueber A-O, Zornig M, Lyon D, Suda T, Nagata S and Evan GI (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278: 1305-1309
13. Falk MH, Trauth BC, Debatin KM, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH and Bornkamm GW (1992) Expression of the APO-1 antigen in Burkitt Lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79: 3300-3306
14. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K and Yonehara S (1994) Anti-Fas on non-hematopoietic tumours: Levels of Fas/APO-1 and bcl-2 are not predictive of biological reponsiveness. Cancer Res. 54: 1580-1586
15. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K and Kishimoto T (1995) Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 85: 757-764
16. Komada Y, Zhou YW, Zhang XL, Xue HL, Sakai H, Tanaka S. Sakatoku H and Sakurai M (1995) Fas receptor (CD95)-mediated apoptosis is induced in leukaemic cells entering G1B compartment of the cell cycle. Blood 86: 3848-3860
17. Cascino I, Papoff G, De Maria R, Testi Rand Ruberti G (1996) Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signalling domain protects tumour cells from Fas mediated apoptosis. J. Immunol. 156: 13-17
18. Durandy A, Le Deist F, Emile J-F, Debatin K and Fischer A (1997) Sensitivity of Epstein-Barr virus induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/Fas antibody. Eur. J. Immunol. 27: 538-543
19. Cohen PL and Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann. Rev. Immunol. 9: 243-269
20. Davidson WF, Giese T and Fredrickson TN (1998) Spontaneous development of plasmacytoid tumours in mice with defective Fas-Fas ligand interactions. J. Exp. Med. 187: 1825-1838
21. Peng SL, Robert ME, Hayday AC and Craft J (1996) A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184: 1149-1154
22. Traver D, Akashi K, Weissman IL and Lagasse E (1998) Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9: 47-57
23. Stewart M, Cameron E, Campbell M, McFarlane R, Toth S, Lang K, Onions Dand Neil JC (1993) Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int. J. Cancer 53: 1023-1030
24. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, Stewart M Donehower LA, Onions DE, Neil J and Cameron ER (1995) Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10: 1717-1723
25. + tumours in CD2-myc transgenic mice. Br. J. Cancer 73: 13-17
26. Iiai T, Kimura M, Kawachi Y, Hirokawa K, Watanabe H, Hatakeyama K and Abo T (1995) Characterisation of intermediate T-cell receptor cells expanding in the liver, thymus and otherorgans in autoimmune lpr mice: parallel analysis with their normal counterparts. Immunol. 85: 601-608
27. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI (1995) A modified oestrogen receptor ligand-binding domain as an improved switch foi the regulation of heterologous proteins. Nuc. Acid Res. 23: 1686-1690
28. Jonkers J and Berns A (1996) Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem. Biophys. Acta 1287: 29-57
29. Zornig M, Grzeschiczek A, Kowalski MB, Hartmann KU and Moroy T (1995) Loss of Fas/APO-1 receptor accelerates lymphomagenesis in Eμ L-myc transgenic mice but not in animals affected with MoMuLV. Oncogene 10: 2397-2401
30. Hueber A and Evan GI (1998) Traps to catch unwary oncogenes. Trends Genet. 14: 364-367
31. Russel JH, Rush B, Weaver C and Wang R (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90: 4409-4413
32. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk E, Schooley KA, Goodwin RG, Smith CA, Ramsdell F and Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77
33. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF and Green DR (1995) Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
34. Dhein J, Walczak H, Baumler C, Debatin K and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 438-441
35. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ and Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
36. Watanabe D, Suda T, Hashimoto H and Nagata S (1995) Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14: 12-18
37. Castro JE, Listman JA, Jacobson BA Wang Y, Lopez PA, Ju S, Finn PW and Perkins DL (1996) Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5: 617-627
38. Kishimoto H, Surh CD and Sprent. (1998) A role for fas in negative selection of thymocytes in vivo. J. Exp. Med. 187: 1427-1438
39. Van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T and Berns A (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and n-myc in murine leukaemia virus-induced tumours. Cell 56: 673-682
40. Wang R, Brunner T, Zhang L and Shi Y (1998) Fungal metabolite FR901228 inhibits c-myc and Fas ligand expression. Oncogene 17: 1503-1508
41. Harrington EA, Bennett MR, Fanidi A and Evan GI (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295
42. Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB (1996) Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated myc. Mol. Cel. Biol. 16: 6573-6581
43. Strasser A, Harris AW, Huang DCS, Krammer P and Cory S (1995) Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
44. Moray T, Grzeschiczek A, Petzold S and Hartmann K (1993) Expression of the Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. USA 90: 10734-10738
45. Aggarwal BB, Singh S, LaPushin R and Totpal K (1995) Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364: 5-8
46. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K, Krammer PH and Peter ME (1998) Two CD95 (Apo-1/Fas) signalling pathways. EMBOJ. 17: 1675-1687
47. waf1/cip1. Gene Dev. 8: 2817-2830
48. Hermeking H and Eick D (1994) Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093
49. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E and Prendergast GC (1995) c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11: 2411-2418
50. Hedrick SM, Cohen DI, Neilsen EA and Davis MM (1984) Isolation of cDNA clones encoding T cell-specific membrane associated proteins. Nature 308: 149-153
51. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501